USP39 and cancer: USP39 is frequently overexpressed in a range of cancers, including head and neck squamous cell carcinoma (HNSCC), oral squamous cell carcinoma (OSCC), nasopharyngeal carcinoma (NPC), medullary thyroid carcinoma (MTC), melanoma, and leukemia.